These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 23697589

  • 1. The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study.
    Wen MJ, Hsieh CH, Wu CZ, Hsiao FC, Hsia TL, Hung YJ, Pei D.
    Obes Res Clin Pract; 2013; 7(3):e206-10. PubMed ID: 23697589
    [Abstract] [Full Text] [Related]

  • 2. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR.
    Br J Nutr; 2015 Jun 28; 113(12):1920-30. PubMed ID: 25907896
    [Abstract] [Full Text] [Related]

  • 3. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR, de Oliveira MC, Diniz KG, Ferreira AM, Lima AS, Correia MI, Vilela EG.
    Nutrition; 2016 Sep 28; 32(9):921-7. PubMed ID: 27189907
    [Abstract] [Full Text] [Related]

  • 4. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
    Nayak BS, Ramsingh D, Gooding S, Legall G, Bissram S, Mohammed A, Raychaudhuri A, Sahadeo B, Pandohie V, Figaro K.
    Prim Care Diabetes; 2010 Oct 28; 4(3):187-92. PubMed ID: 20580627
    [Abstract] [Full Text] [Related]

  • 5. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    Matsushita K, Tamakoshi K, Yatsuya H, Wada K, Otsuka R, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H.
    Int J Cardiol; 2008 Mar 14; 124(3):339-44. PubMed ID: 17433469
    [Abstract] [Full Text] [Related]

  • 6. Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis.
    Kontunen P, Vuolteenaho K, Nieminen R, Lehtimäki L, Kautiainen H, Kesäniemi Y, Ukkola O, Kauppi M, Hakala M, Moilanen E.
    Scand J Rheumatol; 2011 Mar 14; 40(4):256-62. PubMed ID: 21453187
    [Abstract] [Full Text] [Related]

  • 7. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
    Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim ÉA, Baracat J, Geloneze B.
    Obesity (Silver Spring); 2013 Mar 14; 21(3):E182-9. PubMed ID: 23404948
    [Abstract] [Full Text] [Related]

  • 8. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
    Walther G, Obert P, Dutheil F, Chapier R, Lesourd B, Naughton G, Courteix D, Vinet A.
    Arterioscler Thromb Vasc Biol; 2015 Apr 14; 35(4):1022-9. PubMed ID: 25657309
    [Abstract] [Full Text] [Related]

  • 9. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome.
    Ahonen TM, Saltevo JT, Kautiainen HJ, Kumpusalo EA, Vanhala MJ.
    Nutr Metab Cardiovasc Dis; 2012 Mar 14; 22(3):285-91. PubMed ID: 21093230
    [Abstract] [Full Text] [Related]

  • 10. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A, Hergenç G, Can G, Küçükdurmaz Z.
    Obesity (Silver Spring); 2009 Mar 14; 17(3):564-70. PubMed ID: 19238142
    [Abstract] [Full Text] [Related]

  • 11. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B, Teelucksingh S, Jagessar A, Maharaj S, Maharaj N.
    Diabetes Metab Syndr; 2013 Mar 14; 7(1):8-11. PubMed ID: 23517788
    [Abstract] [Full Text] [Related]

  • 12. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J, McQuillan BM, Thompson PL, Beilby JP.
    Int J Obes (Lond); 2008 May 14; 32(5):772-9. PubMed ID: 18253163
    [Abstract] [Full Text] [Related]

  • 13. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM, Sellers EA, Burr LL, Taylor CG.
    Pediatr Diabetes; 2009 Jun 14; 10(4):269-77. PubMed ID: 19175895
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG, Goicoechea M, Kanter J, Puerta M, Cachofeiro V, Lahera V, Gómez-Campderá F, Luño J.
    J Am Soc Nephrol; 2006 Dec 14; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [Abstract] [Full Text] [Related]

  • 15. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE, Vendramini MB, Bueno C, Bonfá E, de Carvalho JF.
    Clin Exp Rheumatol; 2012 Dec 14; 30(6):871-8. PubMed ID: 22935544
    [Abstract] [Full Text] [Related]

  • 16. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb 14; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: role of biomarkers.
    Kanbak G, Akalin A, Dokumacioglu A, Ozcelik E, Bal C.
    Diabetes Metab Syndr; 2011 Feb 14; 5(1):7-11. PubMed ID: 22814834
    [Abstract] [Full Text] [Related]

  • 18. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome.
    Schindler K, Vila G, Hoppichler F, Lechleitner M, Luger A, Anderwald C, Hoefler J, Tomasec G, Kautzky-Willer A, Ludvik B.
    Obes Facts; 2012 Feb 14; 5(2):270-6. PubMed ID: 22647307
    [Abstract] [Full Text] [Related]

  • 19. Waist circumference is positively correlated with markers of inflammation and negatively with adiponectin in women with metabolic syndrome.
    Ackermann D, Jones J, Barona J, Calle MC, Kim JE, LaPia B, Volek JS, McIntosh M, Kalynych C, Najm W, Lerman RH, Fernandez ML.
    Nutr Res; 2011 Mar 14; 31(3):197-204. PubMed ID: 21481713
    [Abstract] [Full Text] [Related]

  • 20. Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization.
    Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, Papassotiriou I, Chrousos GP.
    Fertil Steril; 2010 Oct 14; 94(5):1693-9. PubMed ID: 20045517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.